Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rubler, 1972, New type of cardiomyopathy associated with diabetic glomerulosclerosis, Am. J. Cardiol., 30, 595, 10.1016/0002-9149(72)90595-4
Kannel, 1974, Role of diabetes in congestive heart failure: the Framingham study, Am. J. Cardiol., 34, 29, 10.1016/0002-9149(74)90089-7
Aronow, 1999, Incidence of heart failure in 2,737 older persons with and without diabetes mellitus, Chest, 115, 867, 10.1378/chest.115.3.867
Bertoni, 2003, Diabetes and idiopathic cardiomyopathy: a nationwide case– control study, Diabetes Care, 26, 2791, 10.2337/diacare.26.10.2791
Zhou, 2009, Prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population: systematic review, Curr. Diabetes Rev., 5, 171, 10.2174/157339909788920938
Movahed, 2005, Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease, Int. J. Cardiol., 105, 315, 10.1016/j.ijcard.2005.02.050
Pacher, 2007, Nitric oxide and peroxynitrite in health and disease, Physiol. Rev., 87, 315, 10.1152/physrev.00029.2006
Huynh, 2014, Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways, Pharmacol. Ther., 142, 375, 10.1016/j.pharmthera.2014.01.003
Joshi, 2014, Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria, Mol. Cell. Biochem., 386, 233, 10.1007/s11010-013-1861-x
Isfort, 2014, Metabolic dysfunction in diabetic cardiomyopathy, Heart Fail. Rev., 19, 35, 10.1007/s10741-013-9377-8
Kuethe, 2007, Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy?, Horm. Metab. Res., 39, 672, 10.1055/s-2007-985823
Pacher, 2005, Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme, Antioxid. Redox Signal., 7, 1568, 10.1089/ars.2005.7.1568
Kobayashi, 2015, Autophagy and mitophagy in diabetic cardiomyopathy, Biochim. Biophys. Acta, 252, 10.1016/j.bbadis.2014.05.020
Brownlee, 1981, The biochemistry of the complications of diabetes mellitus, Annu. Rev. Biochem., 50, 385, 10.1146/annurev.bi.50.070181.002125
Sarkozy, 2013, Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats, Cardiovasc. Diabetol., 12, 16, 10.1186/1475-2840-12-16
Miki, 2013, Diabetic cardiomyopathy: pathophysiology and clinical features, Heart Fail. Rev., 18, 149, 10.1007/s10741-012-9313-3
Boudina, 2007, Diabetic cardiomyopathy revisited, Circulation, 115, 3213, 10.1161/CIRCULATIONAHA.106.679597
Jay, 2006, Oxidative stress and diabetic cardiovascular complications, Free Radic. Biol. Med., 40, 183, 10.1016/j.freeradbiomed.2005.06.018
Pacher, 2006, Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes, Curr. Opin. Pharmacol., 6, 136, 10.1016/j.coph.2006.01.001
Giacco, 2010, Oxidative stress and diabetic complications, Circ. Res., 107, 1058, 10.1161/CIRCRESAHA.110.223545
Ma, 2009, Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy, J. Cell. Mol. Med., 13, 1751, 10.1111/j.1582-4934.2008.00547.x
Cai, 2006, Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy, Free Radic. Biol. Med., 41, 851, 10.1016/j.freeradbiomed.2006.06.007
Cai, 2001, Oxidative stress and diabetic cardiomyopathy: a brief review, Cardiovasc. Toxicol., 1, 181, 10.1385/CT:1:3:181
Cai, 2005, Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy, Diabetes, 54, 1829, 10.2337/diabetes.54.6.1829
Szabo, 2002, Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity, Circulation, 106, 2680, 10.1161/01.CIR.0000038365.78031.9C
Ross, 2011, Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes, Curr. Med. Res. Opin., 27, 13, 10.1185/03007995.2011.621416
Ihnat, 2007, Reactive oxygen species mediate a cellular ‘memory’ of high glucose stress signalling, Diabetologia, 50, 1523, 10.1007/s00125-007-0684-2
Fu, 1998, Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins, Biochem. J., 330, 233, 10.1042/bj3300233
Dunlop, 2009, Oxidized proteins: mechanisms of removal and consequences of accumulation, IUBMB Life, 61, 522, 10.1002/iub.189
Kiffin, 2006, Oxidative stress and autophagy, Antioxid. Redox Signal., 8, 152, 10.1089/ars.2006.8.152
Scherz-Shouval, 2007, Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4, EMBO J., 26, 1749, 10.1038/sj.emboj.7601623
Hill, 2008, Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells, Biochem. J., 410, 525, 10.1042/BJ20071063
Rajesh, 2010, Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy, J. Am. Coll. Cardiol., 56, 2115, 10.1016/j.jacc.2010.07.033
Rajesh, 2012, Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy, Diabetes, 61, 716, 10.2337/db11-0477
Roe, 2011, Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction, Diabetes Obes. Metab., 13, 465, 10.1111/j.1463-1326.2011.01369.x
Pacher, 2006, Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol, Pharmacol. Rev., 58, 87, 10.1124/pr.58.1.6
Rajesh, 2009, Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy, J. Cell. Mol. Med., 13, 2330, 10.1111/j.1582-4934.2008.00564.x
Santos, 2003, Diabetes and mitochondrial oxidative stress: a study using heart mitochondria from the diabetic Goto-Kakizaki rat, Mol. Cell. Biochem., 246, 163, 10.1023/A:1023475022025
Du, 2008, Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes, Diabetologia, 51, 1930, 10.1007/s00125-008-1100-2
Camici, 2007, Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress, Proc. Natl. Acad. Sci. U. S. A., 104, 5217, 10.1073/pnas.0609656104
Luo, 2013, Diabetes increases mortality after myocardial infarction by oxidizing CaMKII, J. Clin. Invest., 123, 1262, 10.1172/JCI65268
Supinski, 2009, MitoQ administration prevents endotoxin-induced cardiac dysfunction, Am. J. Physiol. Regul. Integr. Comp. Physiol., 297, R1095, 10.1152/ajpregu.90902.2008
Rao, 2010, The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone, J. Biol. Chem., 285, 34447, 10.1074/jbc.M110.133579
Gao, 2009, Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling, Cardiovasc. Res., 82, 9, 10.1093/cvr/cvp031
Maalouf, 2012, Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes, Am. J. Physiol. Cell Physiol., 302, C597, 10.1152/ajpcell.00331.2011
Varga, 2013, MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart, J. Mol. Cell. Cardiol., 62, 111, 10.1016/j.yjmcc.2013.05.009
Altenhofer, 2012, The NOX toolbox: validating the role of NADPH oxidases in physiology and disease, Cell. Mol. Life Sci., 69, 2327, 10.1007/s00018-012-1010-9
Serpillon, 2009, Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH, Am. J. Physiol. Heart Circ. Physiol., 297, H153, 10.1152/ajpheart.01142.2008
Scherz-Shouval, 2007, Oxidation as a post-translational modification that regulates autophagy, Autophagy, 3, 371, 10.4161/auto.4214
Wu, 2010, Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local Ras activation, Mol. Cell. Biol., 30, 3553, 10.1128/MCB.01445-09
Zhou, 2008, Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart, J. Am. Coll. Cardiol., 52, 655, 10.1016/j.jacc.2008.05.019
Westermann, 2007, Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism, Diabetes, 56, 641, 10.2337/db06-1163
Kajstura, 2001, IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress, Diabetes, 50, 1414, 10.2337/diabetes.50.6.1414
Fiordaliso, 2000, Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent, Lab. Investig., 80, 513, 10.1038/labinvest.3780057
Frustaci, 2000, Myocardial cell death in human diabetes, Circ. Res., 87, 1123, 10.1161/01.RES.87.12.1123
Privratsky, 2003, AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase, Hypertension, 42, 206, 10.1161/01.HYP.0000082814.62655.85
Desco, 2002, Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol, Diabetes, 51, 1118, 10.2337/diabetes.51.4.1118
Gao, 2012, Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes, Diabetes Metab. Res. Rev., 28, 409, 10.1002/dmrr.2295
Szwejkowski, 2013, Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy, J. Am. Coll. Cardiol., 62, 2284, 10.1016/j.jacc.2013.07.074
Rekhraj, 2013, High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease, J. Am. Coll. Cardiol., 61, 926, 10.1016/j.jacc.2012.09.066
Pacher, 2005, Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies, Curr. Med. Chem., 12, 267, 10.2174/0929867053363207
Zou, 2002, Oxidation of the zinc–thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite, J. Clin. Invest., 109, 817, 10.1172/JCI0214442
Jo, 2011, Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice, Clin. Exp. Pharmacol. Physiol., 38, 485, 10.1111/j.1440-1681.2011.05535.x
Okazaki, 2011, Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia/reperfusion injury in diabetic rat heart, Free Radic. Res., 45, 1173, 10.3109/10715762.2011.605361
Farhangkhoee, 2003, Heme oxygenase in diabetes-induced oxidative stress in the heart, J. Mol. Cell. Cardiol., 35, 1439, 10.1016/j.yjmcc.2003.09.007
Stockklauser-Farber, 2000, Influence of diabetes on cardiac nitric oxide synthase expression and activity, Biochim. Biophys. Acta, 1535, 10, 10.1016/S0925-4439(00)00078-8
Cassuto, 2014, Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients, Diabetes, 63, 1381, 10.2337/db13-0577
Smith, 1997, Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats, J. Mol. Cell. Cardiol., 29, 2393, 10.1006/jmcc.1997.0474
Esberg, 2003, Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes, Diabetologia, 46, 1419, 10.1007/s00125-003-1183-8
Sarkar, 2011, Complex inhibitory effects of nitric oxide on autophagy, Mol. Cell, 43, 19, 10.1016/j.molcel.2011.04.029
Yuan, 2009, LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection, Am. J. Physiol. Heart Circ. Physiol., 296, H470, 10.1152/ajpheart.01051.2008
Han, 2011, Regulation of the ischemia-induced autophagy-lysosome processes by nitrosative stress in endothelial cells, J. Pineal Res., 51, 124, 10.1111/j.1600-079X.2011.00869.x
Pacher, 2005, Nitrosative stress and pharmacological modulation of heart failure, Trends Pharmacol. Sci., 26, 302, 10.1016/j.tips.2005.04.003
Evgenov, 2006, NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential, Nat. Rev. Drug Discov., 5, 755, 10.1038/nrd2038
Stasch, 2011, Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease, Circulation, 123, 2263, 10.1161/CIRCULATIONAHA.110.981738
Hoeldtke, 2003, Peroxynitrite versus nitric oxide in early diabetes, Am. J. Hypertens., 16, 761, 10.1016/S0895-7061(03)00976-2
Wang, 2009, Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling, Diabetes, 58, 1391, 10.2337/db08-1697
Wang, 2006, Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation, Circulation, 113, 544, 10.1161/CIRCULATIONAHA.105.537894
Cong, 2014, Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase, J. Nutr. Biochem., 25, 463, 10.1016/j.jnutbio.2013.12.007
He, 2009, Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes, J. Mol. Cell. Cardiol., 46, 47, 10.1016/j.yjmcc.2008.10.007
Li, 2012, Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy, Exp. Diabetes Res., 2012, 216512, 10.1155/2012/216512
Stadler, 2011, Peroxynitrite-driven mechanisms in diabetes and insulin resistance—the latest advances, Curr. Med. Chem., 18, 280, 10.2174/092986711794088317
Candido, 2003, A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes, Circ. Res., 92, 785, 10.1161/01.RES.0000065620.39919.20
Bidasee, 2004, Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase, Diabetes, 53, 463, 10.2337/diabetes.53.2.463
van Heerebeek, 2008, Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension, Circulation, 117, 43, 10.1161/CIRCULATIONAHA.107.728550
Mei, 2015, Autophagy and oxidative stress in cardiovascular diseases, Biochim. Biophys. Acta, 243, 10.1016/j.bbadis.2014.05.005
Dong, 2010, Autophagy: definition, molecular machinery, and potential role in myocardial ischemia–reperfusion injury, J. Cardiovasc. Pharmacol. Ther., 15, 220, 10.1177/1074248410370327
Martinet, 2007, Autophagy in cardiovascular disease, Trends Mol. Med., 13, 482, 10.1016/j.molmed.2007.08.004
Nakai, 2007, The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress, Nat. Med., 13, 619, 10.1038/nm1574
Campesi, 2013, Protein oxidation seems to be linked to constitutive autophagy: a sex study, Life Sci., 93, 145, 10.1016/j.lfs.2013.06.001
Ren, 2004, Diabetic cardiomyopathy: do women differ from men?, Endocrine, 25, 73, 10.1385/ENDO:25:2:073
Zhao, 2013, Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy, PLoS One, 8, e75927, 10.1371/journal.pone.0075927
Abel, 2012, Insulin resistance: metabolic mechanisms and consequences in the heart, Arterioscler. Thromb. Vasc. Biol., 32, 2068, 10.1161/ATVBAHA.111.241984
Xie, 2011, Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice, Diabetes, 60, 1770, 10.2337/db10-0351
Xie, 2011, AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy, Autophagy, 7, 1254, 10.4161/auto.7.10.16740
Younce, 2010, Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP, Cardiovasc. Res., 87, 665, 10.1093/cvr/cvq102
Giricz, 2012, Autophagy, myocardial protection, and the metabolic syndrome, J. Cardiovasc. Pharmacol., 60, 125, 10.1097/FJC.0b013e318256ce10
Deng, 2007, Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats, Am. J. Physiol. Heart Circ. Physiol., 293, H978, 10.1152/ajpheart.01002.2006
He, 2013, Dissociation of Bcl-2–Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes, Diabetes, 62, 1270, 10.2337/db12-0533
Mellor, 2011, Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice, J. Mol. Cell. Cardiol., 50, 1035, 10.1016/j.yjmcc.2011.03.002
Russo, 2012, Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes, J. Clin. Invest., 122, 3919, 10.1172/JCI63888
Volkers, 2014, PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity, EMBO Mol. Med., 6, 57, 10.1002/emmm.201303183
He, 2012, Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein, Mol. Pharmacol., 82, 887, 10.1124/mol.112.081133
Kobayashi, 2012, Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury, Autophagy, 8, 577, 10.4161/auto.18980
Xu, 2013, Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes, J. Biol. Chem., 288, 18077, 10.1074/jbc.M113.474650
Bai, 2012, The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease, Cell Metab., 16, 290, 10.1016/j.cmet.2012.06.016
Pacher, 2008, Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease, Am. J. Pathol., 173, 2, 10.2353/ajpath.2008.080019
Bai, 2011, PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation, Cell Metab., 13, 461, 10.1016/j.cmet.2011.03.004
Bai, 2011, PARP-2 regulates SIRT1 expression and whole-body energy expenditure, Cell Metab., 13, 450, 10.1016/j.cmet.2011.03.013
Mukhopadhyay, 2014, Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis, Hepatology, 59, 1998, 10.1002/hep.26763
Garcia Soriano, 2001, Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation, Nat. Med., 7, 108, 10.1038/83241
Soriano, 2001, Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase, Circ. Res., 89, 684, 10.1161/hh2001.097797
Pacher, 2002, The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes, Diabetes, 51, 514, 10.2337/diabetes.51.2.514
Tschope, 2005, Transgenic activation of the kallikrein–kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy, FASEB J., 19, 2057, 10.1096/fj.05-4095fje
Westermann, 2007, Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy, Basic Res. Cardiol., 102, 500, 10.1007/s00395-007-0673-0
Westermann, 2009, Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy, Diabetes, 58, 1373, 10.2337/db08-0329
Westermann, 2006, Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus, Diabetologia, 49, 2507, 10.1007/s00125-006-0385-2
Becher, 2013, Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis, Int. J. Mol. Med., 32, 158, 10.3892/ijmm.2013.1368
Mariappan, 2010, NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes, Cardiovasc. Res., 85, 473, 10.1093/cvr/cvp305
Chen, 2007, Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes, Circ. J., 71, 144, 10.1253/circj.71.144
Al-Attas, 2009, Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies, Cardiovasc. Diabetol., 8, 20, 10.1186/1475-2840-8-20
Elrashidy, 2012, Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy, J. Pharm. Pharmacol., 64, 862, 10.1111/j.2042-7158.2012.01508.x
Ferdinandy, 2000, Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure, Circ. Res., 87, 241, 10.1161/01.RES.87.3.241
Mukhopadhyay, 2009, Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro, Am. J. Physiol. Heart Circ. Physiol., 296, H1466, 10.1152/ajpheart.00795.2008
Levrand, 2006, Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo, Free Radic. Biol. Med., 41, 886, 10.1016/j.freeradbiomed.2006.04.034
Nian, 2004, Inflammatory cytokines and postmyocardial infarction remodeling, Circ. Res., 94, 1543, 10.1161/01.RES.0000130526.20854.fa
Li, 2000, Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy, Proc. Natl. Acad. Sci. U. S. A., 97, 12746, 10.1073/pnas.97.23.12746
Pacher, 2006, The endocannabinoid system as an emerging target of pharmacotherapy, Pharmacol. Rev., 58, 389, 10.1124/pr.58.3.2
Engeli, 2005, Activation of the peripheral endocannabinoid system in human obesity, Diabetes, 54, 2838, 10.2337/diabetes.54.10.2838
Jourdan, 2013, Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes, Nat. Med., 19, 1132, 10.1038/nm.3265
Oh, 2013, Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos, Mol. Hum. Reprod., 19, 93, 10.1093/molehr/gas049
Koay, 2014, Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium, Am. J. Physiol. Gastrointest. Liver Physiol., 10.1152/ajpgi.00317.2013
Toldo, 2011, Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase, Mol. Med., 17, 1012, 10.2119/molmed.2011.00100
Baseler, 2011, Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction, Am. J. Physiol. Regul. Integr. Comp. Physiol., 300, R186, 10.1152/ajpregu.00423.2010
Lu, 2010, Oxidative and nitrative modifications of alpha-enolase in cardiac proteins from diabetic rats, Free Radic. Biol. Med., 48, 873, 10.1016/j.freeradbiomed.2010.01.010
Turko, 2001, Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase, Am. J. Physiol. Heart Circ. Physiol., 281, H2289, 10.1152/ajpheart.2001.281.6.H2289
Turko, 2003, Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes, J. Biol. Chem., 278, 33972, 10.1074/jbc.M303734200
Cong, 2013, Metallothionein prevents diabetes-induced cardiac pathological changes, likely via the inhibition of succinyl-CoA:3-ketoacid coenzyme A transferase-1 nitration at Trp(374), Am. J. Physiol. Endocrinol. Metab., 304, E826, 10.1152/ajpendo.00570.2012
Dennis, 2013, Augmented cardiac formation of oxidatively-induced carbonylated proteins accompanies the increased functional severity of post-myocardial infarction heart failure in the setting of type 1 diabetes mellitus, Cardiovasc. Pathol., 22, 473, 10.1016/j.carpath.2013.03.001
Shao, 2012, Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus, Mol. Pharmacol., 82, 383, 10.1124/mol.112.078352
Shao, 2011, Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes, Diabetes, 60, 947, 10.2337/db10-1145
Shao, 2010, Carbonylation of myosin heavy chains in rat heart during diabetes, Biochem. Pharmacol., 80, 205, 10.1016/j.bcp.2010.03.024
Puthanveetil, 2012, Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1, J. Mol. Cell. Cardiol., 53, 677, 10.1016/j.yjmcc.2012.08.013
Joshi, 2014, Alterations in connexin 43 during diabetic cardiomyopathy: competition of tyrosine nitration versus phosphorylation, J. Diabetes
Yin, 2010, Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury, J. Mol. Cell. Cardiol., 49, 354, 10.1016/j.yjmcc.2010.05.002
Luan, 2009, High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation, Cardiovasc. Res., 83, 294, 10.1093/cvr/cvp085
Gorin, 2013, Nox as a target for diabetic complications, Clin. Sci. (Lond.), 125, 361, 10.1042/CS20130065
Teng, 2012, Cross talk between NADPH oxidase and autophagy in pulmonary artery endothelial cells with intrauterine persistent pulmonary hypertension, Am. J. Physiol. Lung Cell. Mol. Physiol., 302, L651, 10.1152/ajplung.00177.2011
Wang, 2013, Regulation of autophagy and apoptosis in response to angiotensin II in HL-1 cardiomyocytes, Biochem. Biophys. Res. Commun., 440, 696, 10.1016/j.bbrc.2013.09.131
Settergren, 2009, L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease, Atherosclerosis, 204, 73, 10.1016/j.atherosclerosis.2008.08.034
Garcia-Navas, 2012, Depletion of l-arginine induces autophagy as a cytoprotective response to endoplasmic reticulum stress in human T lymphocytes, Autophagy, 8, 1557, 10.4161/auto.21315
Kwak, 2011, Autophagy induction by tetrahydrobiopterin deficiency, Autophagy, 7, 1323, 10.4161/auto.7.11.16627
Ren, 2008, IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction, Am. J. Physiol. Regul. Integr. Comp. Physiol., 294, R793, 10.1152/ajpregu.00713.2007
Troncoso, 2012, Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy, Cardiovasc. Res., 93, 320, 10.1093/cvr/cvr321
Soliman, 2008, Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats, Cardiovasc. Res., 79, 322, 10.1093/cvr/cvn095
Nagareddy, 2009, Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats, Eur. J. Pharmacol., 611, 53, 10.1016/j.ejphar.2009.03.061
Szabo, 2002, Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst, Mol. Med., 8, 571, 10.1007/BF03402167
Bai, 2013, Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation, J. Mol. Cell. Cardiol., 57, 82, 10.1016/j.yjmcc.2013.01.008
Herman-Antosiewicz, 2006, Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells, Cancer Res., 66, 5828, 10.1158/0008-5472.CAN-06-0139
Tan, 2011, Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo, Diabetes, 60, 625, 10.2337/db10-1164
Guo, 2013, The protective effect of fasudil on the structure and function of cardiac mitochondria from rats with type 2 diabetes induced by streptozotocin with a high-fat diet is mediated by the attenuation of oxidative stress, Biomed. Res. Int., 2013, 430791, 10.1155/2013/430791
Iorio, 2010, Identification of small molecules enhancing autophagic function from drug network analysis, Autophagy, 6, 1204, 10.4161/auto.6.8.13551
Riad, 2007, Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus, Eur. J. Pharmacol., 554, 40, 10.1016/j.ejphar.2006.08.065
Chiu, 2008, PARP mediates structural alterations in diabetic cardiomyopathy, J. Mol. Cell. Cardiol., 45, 385, 10.1016/j.yjmcc.2008.06.009
Zhou, 2013, Poly(ADP-ribose) polymerase-1 regulates the mechanism of irradiation-induced CNE-2 human nasopharyngeal carcinoma cell autophagy and inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells, Oncol. Rep., 29, 2498, 10.3892/or.2013.2382
Monji, 2013, Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes, Am. J. Physiol. Heart Circ. Physiol., 305, H295, 10.1152/ajpheart.00990.2012
Aroor, 2013, Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats, Endocrinology, 154, 2501, 10.1210/en.2013-1096
Picatoste, 2013, Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms, PLoS One, 8, e78330, 10.1371/journal.pone.0078330
Liu, 2013, Glucagon-like peptide-1 analog liraglutide protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway, J. Diabetes Res., 2013, 630537, 10.1155/2013/630537
Guo, 2014, Effect of exenatide on the cardiac expression of adiponectin receptor 1 and NADPH oxidase subunits and heart function in streptozotocin-induced diabetic rats, Diabetol. Metab. Syndr., 6, 29, 10.1186/1758-5996-6-29